Bronchopulmonary Dysplasia in a Tertiary Level Neonatal Unit of North India: Risk Factors and Outcome: A Case-control Study
Abstract
Background
Bronchopulmonary dysplasia (BPD) in preterm neonates is a dreadful complication that increases the length of neonatal intensive care unit (NICU) stay, increases the cost of treatment, and poses long-term respiratory morbidity.
Methods
This was a case-control study to determine risk factors for BPD among preterm neonates (gestational age <32 weeks). Also, the proportion of BPD neonates developing secondary pulmonary arterial hypertension (PAH), vitamin D levels, and their outcomes were studied.
Results
Of 70 neonates with a mean birth weight of 1392 ± 544.28 grams and a mean gestational age of 30.14 ± 1.12 weeks, 35 cases of BPD (mild 42%, moderate 27%, severe 31%) and 35 controls were enrolled. After multivariate analysis, SGA (adjusted odds ratio [AOR] 12.6 with 95% CI 1.5-109.3; 0.022), lack of antenatal steroids (AOR 9.4 with 95% CI 1.8-50.7; 0.009), mechanical ventilation [MV] within the first 48 hours of life (AOR 8.7 with 95% CI 1.4-54.1; 0.021), and lack of surfactant administration (AOR 16.5% CI 3-89.1; 0.005) were independent risk factors. No significant difference was reported in vitamin D levels between BPD and non-BPD neonates (33.89 ± 22.50 ng/mL vs. 27.00 ± 8.17 ng/mL; 0.356). 14.3 % of BPD neonates expired, and 23% developed PAH. Neonates had a longer NICU stay than controls (46.66 ± 7.96 vs. 21 ± 8.82 days; <0.001)
Conclusion
We found SGA, lack of antenatal steroids, MV, and lack of surfactant administration to be independent risk factors for BPD. BPD neonates had dismal outcomes (one-fourth expired and left against medical advice), and one-fifth had PAH among survivors, increasing the length of their NICU stay.
Get full access to this article
View all access and purchase options for this article.
References
1. Reddy KM, Ravula SR, Palakollu S, Betha K. Prevalence of preterm birth and perinatal outcome: a rural tertiary teaching hospital-based study. J Family Med Prim Care. 2022;11(7):3909–3914. doi:10.4103/jfmpc.jfmpc_1440_21.
2. Jensen EA, Schmidt B. Epidemiology of bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol. 2014;100(3):145–157. doi:10.1002/bdra.23235
3. Keszler M. Volume-targeted ventilation: one size does not fit all. Evidence-based recommendations for successful use. Arch Dis Child Fetal Neonatal Ed. 2019;104:F108–F112. doi:10.1136/archdischild-2017-314734
4. Lapcharoensap W, Gage SC, Kan P, et al. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort. JAMA Pediatr. 2015;169(2):e143676. doi:10.1001/jamapediatrics.2014.3676
5. Cokyaman T, Kavuncuoglu S. Bronchopulmonary dysplasia frequency and risk factors in very low birth weight infants: a 3-year retrospective study. North Clin Istanb. 2019;7(2):124–130. doi:10.14744/nci.2019.23427
6. Bhunwal S, Mukhopadhyay K, Bhattacharya S, Dey P, Dhaliwal LK. Bronchopulmonary dysplasia in preterm neonates in a level III neonatal unit in India. Indian Pediatr. 2018;55(3):211–215.
7. Diggikar S, Aradhya AS, LokanadhaReddy V, Jaganathan P, Mulage L. Risk factors for bronchopulmonary dysplasia in a level-III neonatal unit. Indian J Pediatr. 2021:88;497–498.
8. Hansmann G, Sallmon H, Roehr CC, et al. Pulmonary hypertension in bronchopulmonary dysplasia. Pediatr Res. 2021;89(3):446–455. doi:10.1038/s41390-020-0993-4
9. Park HW, Lim G, Y-M Park, et al. Association between vitamin D level and bronchopulmonary dysplasia: a systematic review and meta-analysis. PLoS ONE. 2020;15(7):e0235332. doi:10.1371/journal.pone.0235332
10. Jensen EA, Dysart K, Gantz MG, et al. The diagnosis of bronchopulmonary dysplasia in very preterm infants. An evidence-based approach. Am J Respir Crit Care Med. 2019;200(6):751–759. doi:10.1164/rccm.201812-2348OC
11. Terrin G, Di Chiara M, Boscarino G, et al. Echocardiography-guided management of preterms with patent ductus arteriosus influences the outcome: a cohort study. Front Pediatr. 2020;8:582735. doi:10.3389/fped.2020.582735
12. Mohakud NK, Mishra JP, Nayak MK, et al. Bacteriological profile and outcome of culture-positive neonatal sepsis in a special newborn care unit setting, Odisha. Cureus. 2022;14(5):e25539. doi:10.7759/cureus.25539
13. Neu J. Necrotizing enterocolitis: the search for a unifying pathogenic theory leading to prevention. Pediatr Clin North Am. 1996;43(2):409–432. doi:10.1016/s0031-3955(05)70413-2
14. Mourani PM, Abman SH. Pulmonary hypertension and vascular abnormalities in bronchopulmonary dysplasia. Clin Perinatol. 2015;42(4):839–855. doi:10.1016/j.clp.2015.08.010
15. Hernández-Ronquillo L, Téllez-Zenteno JF, Weder-Cisneros N, Salinas-Ramírez V Zapata-Pallagi JA, da Silva O. Risk factors for the development of bronchopulmonary dysplasia: a case-control study. Arch Med Res. 2004;35(6):549–553. doi:10.1016/j.arcmed.2004.07.001
16. Narang A, Kumar P, Kumar R. Chronic lung disease in neonates: emerging problem in India. Indian Pediatr. 2002;39(2):158–162.
17. Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;3(3):CD004454. doi:10.1002/14651858.CD004454.pub3.
18. Keszler M. Volume-targeted ventilation: one size does not fit all. Evidence-based recommendations for successful use. Arch Dis Child Fetal Neonatal Ed. 2019;104:F108–F112. doi:10.1136/ archdischild-2017-314734
19. Herting E, Härtel C, Göpel W. Less invasive surfactant administration: best practices and unanswered questions. Curr Opin Pediatr. 2020;32(2):228–234. doi:10.1097/MOP.0000000000000878.
20. Zhang X, Chu X, Weng B, Gong X, Cai C. An innovative model of bronchopulmonary dysplasia in premature infants. Front Pediatr. 2020;8:271. doi:10.3389/fped.2020.00271
21. Biniwale MA, Ehrenkranz RA. The role of nutrition in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol. 2006;30(4):200–208. doi:10.1053/j.semperi.2006.05.007
22. Cetinkaya M, Cekmez F, Buyukkale G, et al. Lower vitamin D levels are associated with increased risk of early-onset neonatal sepsis in term infants. J Perinatol. 2015;35(1):39–45. doi:10.1038/jp.2014.146
23. Weismann CG, Asnes JD, Bazzy-Asaad A, Tolomeo C, Ehrenkranz RA, Bizzarro MJ. Pulmonary hypertension in preterm infants: results of a prospective screening program. J. Perinatol. 2017; 37(5):572–577.
24. Mowitz ME, Ayyagari R, Gao W, Zhao J, Mangili A, Sarda SP. Health care burden of bronchopulmonary dysplasia among extremely preterm infants. Front Pediatr. 2019 Dec 12;7:510. doi:10.3389/fped.2019.00510.
Cite article
Cite article
Cite article
OR
Download to reference manager
If you have citation software installed, you can download article citation data to the citation manager of your choice
Information, rights and permissions
Information
Published In
Article first published online: March 22, 2024
Issue published: December 2024
Keywords
Authors
Metrics and citations
Metrics
Article usage*
Total views and downloads: 69
*Article usage tracking started in December 2016
Articles citing this one
Receive email alerts when this article is cited
Web of Science: 0
Crossref: 0
There are no citing articles to show.
Figures and tables
Figures & Media
Tables
Get access
Get access
Access options
If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:
I am signed in as:
View my profileSign out
I can access personal subscriptions, purchases, paired institutional access and free tools such as favourite journals, email alerts and saved searches.
Access journal content via a university, library or employer subscription.
Alternatively, view purchase options below:
Purchase 24 hour online access to view and download content.
Access journal content via a DeepDyve subscription or find out more about this option.
